Association Between Gender and Drug Cost for Over-the-Counter Minoxidil
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2017.1394
Abstract: Association Between Gender and Drug Cost for Over-the-Counter Minoxidil Minoxidil is a US Food and Drug Administration (FDA)– approved over-the-counter topical medication for androgenetic alopecia marketed and sold to men and women. Approximately 50 million… read more here.
Keywords: minoxidil; drug cost; cost counter; gender drug ... See more keywords
Minoxidil–2-hydroxypropyl-β-cyclodextrin inclusion complexes: characterization and in vivo evaluation of an aqueous solution for hair growth in rats
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Inclusion Phenomena and Macrocyclic Chemistry"
DOI: 10.1007/s10847-017-0705-9
Abstract: Minoxidil dissolved in organic solvents is commonly used in the treatment of androgenic alopecia because it is hydrophobic and poorly soluble in water. The aim of this investigation was to develop an aqueous minoxidil solution… read more here.
Keywords: inclusion; minoxidil; hydroxypropyl cyclodextrin; inclusion complexes ... See more keywords
Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
Sign Up to like & getrecommendations! Published in 2024 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01197-x
Abstract: The minimal adverse-effect profile and positive clinical response of low-dose oral minoxidil (LDOM) have recently caused the drug to gain popularity for the treatment of hair disorders in adults. However, in the pediatric population, hesitancy… read more here.
Keywords: treatment; oral minoxidil; minoxidil; review ... See more keywords
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2109567
Abstract: Abstract Background Androgenetic alopecia (AGA) is the most common cause of hair loss, often challenging to treat. While oral finasteride (1 mg/d) is an FDA-approved treatment for male AGA, oral minoxidil and oral dutasteride are not… read more here.
Keywords: androgenetic alopecia; minoxidil finasteride; finasteride dutasteride; minoxidil ... See more keywords
Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice.
Sign Up to like & getrecommendations! Published in 2017 at "Rejuvenation research"
DOI: 10.1089/rej.2016.1874
Abstract: Normal arterial aging processes involve vascular cell dysfunction associated with wall stiffening, the latter being due to progressive elastin and elastic fiber degradation, and elastin and collagen cross-linking by advanced glycation end products (AGEs). These… read more here.
Keywords: elastic fiber; minoxidil; treatment minoxidil; aorta ... See more keywords
P110 Comparative efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil in androgenetic alopecia: a randomized controlled trial
Sign Up to like & getrecommendations! Published in 2024 at "British Journal of Dermatology"
DOI: 10.1093/bjd/ljae090.137
Abstract: Androgenetic alopecia (AGA) is conventionally managed with topical minoxidil, while platelet-rich plasma (PRP) and oral minoxidil present alternative options. Head-to-head trials are scarce, necessitating a comparative study. This randomized controlled trial aimed to compare the… read more here.
Keywords: low dose; oral minoxidil; topical minoxidil; minoxidil ... See more keywords
O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Dermatology"
DOI: 10.1093/bjd/ljaf085.019
Abstract: Androgenetic alopecia (AA) is characterized by progressive miniaturization of scalp follicles mediated by dihydrotestosterone. Conventional treatments include oral finasteride (a type II 5α-reductase inhibitor) and topical minoxidil, but topical regimens can be limited by application… read more here.
Keywords: low dose; dose oral; oral minoxidil; minoxidil ... See more keywords
Contact dermatitis to minoxidil
Sign Up to like & getrecommendations! Published in 2020 at "Contact Dermatitis"
DOI: 10.1111/cod.13670
Abstract: Topical minoxidil is a safe and effective treatment for patients with androgenetic alopecia. It has a favourable safety profile, but sometimes can cause pruritis, and irritant and allergic contact dermatitis (ACD). ACD to topical minoxidil… read more here.
Keywords: minoxidil contact; minoxidil; contact dermatitis; dermatitis minoxidil ... See more keywords
Unusual clinical presentation of allergic contact dermatitis to topical minoxidil
Sign Up to like & getrecommendations! Published in 2022 at "Contact Dermatitis"
DOI: 10.1111/cod.14117
Abstract: Topical minoxidil is used as the main treatment for androgenetic alopecia (AGA). Its use grew wider COVID-induced effluviums, as it is currently available over the counter. Although it has a satisfying safety profile, minoxidil can… read more here.
Keywords: allergic contact; topical minoxidil; minoxidil; contact dermatitis ... See more keywords
Topical minoxidil‐induced paresthesia
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15328
Abstract: and erythema on the application site, as well as our patient. 1 On the other hand, it has been suggested that excessive topical application may induce systemic absorption, leading to excessive hair growth in non-treated… read more here.
Keywords: minoxidil induced; topical minoxidil; minoxidil; induced paresthesia ... See more keywords
Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15696
Abstract: Alopecia areata (AA) is an autoimmune disease that results in non‐scarring hair loss. Topical minoxidil 5% gel and methotrexate (MTX) 1% gel are important modalities used in the treatment of many dermatological diseases. We aimed… read more here.
Keywords: mtx; minoxidil gel; gel; treatment ... See more keywords